SE9500051D0 - Antioxidants, tissue- and/or neuroprotectants - Google Patents
Antioxidants, tissue- and/or neuroprotectantsInfo
- Publication number
- SE9500051D0 SE9500051D0 SE9500051A SE9500051A SE9500051D0 SE 9500051 D0 SE9500051 D0 SE 9500051D0 SE 9500051 A SE9500051 A SE 9500051A SE 9500051 A SE9500051 A SE 9500051A SE 9500051 D0 SE9500051 D0 SE 9500051D0
- Authority
- SE
- Sweden
- Prior art keywords
- tissue
- formula
- neuroprotectants
- antioxidants
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9500051A SE9500051D0 (sv) | 1995-01-09 | 1995-01-09 | Antioxidants, tissue- and/or neuroprotectants |
| AU44614/96A AU4461496A (en) | 1995-01-09 | 1996-01-09 | The use of heterocyclic compounds as antioxidants, radical scavengers, fe2+ complexing agents, tissue- and/or neuroprotectants |
| PCT/SE1996/000007 WO1996021662A1 (en) | 1995-01-09 | 1996-01-09 | THE USE OF HETEROCYCLIC COMPOUNDS AS ANTIOXIDANTS, RADICAL SCAVENGERS, Fe2+ COMPLEXING AGENTS, TISSUE- AND/OR NEUROPROTECTANTS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9500051A SE9500051D0 (sv) | 1995-01-09 | 1995-01-09 | Antioxidants, tissue- and/or neuroprotectants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9500051D0 true SE9500051D0 (sv) | 1995-01-09 |
Family
ID=20396768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9500051A SE9500051D0 (sv) | 1995-01-09 | 1995-01-09 | Antioxidants, tissue- and/or neuroprotectants |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU4461496A (xx) |
| SE (1) | SE9500051D0 (xx) |
| WO (1) | WO1996021662A1 (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6525053B1 (en) | 1997-08-22 | 2003-02-25 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| US6307047B1 (en) | 1997-08-22 | 2001-10-23 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| US20070155738A1 (en) | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| WO2007113226A1 (en) * | 2006-03-31 | 2007-10-11 | Novartis Ag | Organic compounds |
| AR074830A1 (es) | 2008-12-19 | 2011-02-16 | Cephalon Inc | Pirrolotriazinas como inhibidores de alk y jak2 |
| WO2024059220A2 (en) * | 2022-09-15 | 2024-03-21 | Vanderbilt University | 6,5 southwestern core compounds as mglu5 negative allosteric modulators and methods of making and using the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3333314A1 (de) * | 1983-09-15 | 1985-03-28 | Hoechst Ag, 6230 Frankfurt | Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
-
1995
- 1995-01-09 SE SE9500051A patent/SE9500051D0/xx unknown
-
1996
- 1996-01-09 WO PCT/SE1996/000007 patent/WO1996021662A1/en not_active Ceased
- 1996-01-09 AU AU44614/96A patent/AU4461496A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996021662A1 (en) | 1996-07-18 |
| AU4461496A (en) | 1996-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9506828A (pt) | Composição contendo nebivolol micronizado | |
| BRPI9710372B8 (pt) | composto, e, composição farmacêutica. | |
| DE69522947D1 (en) | Phenylxanthin-derivate | |
| HUT77925A (hu) | Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra | |
| DE69616749D1 (de) | Arylsubstituierte 5,5 verknüpfte aromatische nitroverbindungen als entzündungshemmende wirkstoffe | |
| ES2113127T3 (es) | Derivado de androstenona. | |
| ATE78813T1 (de) | Piperidinderivat, seine verwendung und diese enthaltende pharmazeutische zusammensetzung. | |
| IL92487A0 (en) | Pharmaceutical and cosmetic compositions containing benzimidazoles and benzotriazoles,certain novel benzimidazoles and their preparation | |
| AU7092296A (en) | Pharmaceutical compositions containing hydroximic acid derivatives | |
| ATE25977T1 (de) | Furanonderivate, verfahren zu ihrer herstellung und ihre verwendung. | |
| ES2036926A1 (es) | "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina". | |
| PT85502A (en) | Process for the preparation of novel phenoxyacetic acid derivatives and of pharmaceutical compositions containing the same | |
| NO912888L (no) | Fremgangsmaate for fremstilling av nye peperidylethere og -thioethere. | |
| SE9500051D0 (sv) | Antioxidants, tissue- and/or neuroprotectants | |
| DE60225143D1 (de) | Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes | |
| CA2107485A1 (fr) | Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| ATE13423T1 (de) | Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE3750464D1 (de) | Pharmazeutisches Präparat zur Behandlung des Katarakts. | |
| EP0684042A3 (en) | Solid oral pharmaceutical preparation with gemfibrozil as an active ingredient and manufacturing method. | |
| GEP20032928B (en) | Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections | |
| IL112630A (en) | Derivatives of (2-(ar)alkyldithioindane-2-carboxamido) tricyclic-oxobenzazepine and similar compouds useful as inhibitors of enkephalinase, their preparation and pharmaceutical compositions containing them | |
| FR2452929A1 (fr) | Compositions pharmaceutiques synergiques protegeant contre les rayonnements | |
| NO166713C (no) | Analogifremgangsmaate for fremstikling av terapeutisk aktive monobasiske diisobutamid derivater. | |
| BG103395A (en) | Derivatives of benzenesulphonamide and medicaments containing them | |
| KR910002455A (ko) | 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용 |